WGI-2101

N/A

Report date: 2022/05/10 11:40:25
NME

Base Information

Drug NameWGI-2101
Drug Alias NameMyMirWGI2101
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionRNA interferencemicroRNA 21 inhibitors
TargetsmicroRNA 21
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe WhiteOak Group LLC
China Registration ClassN/A

Develop Information

Active CompaniesThe WhiteOak Group LLC
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A